Polymeric Anti-HIV Therapeutics

被引：22

作者：

Danial, Maarten ^{[1
,2
,3
]}

Klok, Harm-Anton ^{[1
,2
]}

机构：

[1] Ecole Polytech Fed Lausanne, Inst Mat, CH-1015 Lausanne, Switzerland

[2] Inst Sci & Ingn Chim, Lab Polymeres, CH-1015 Lausanne, Switzerland

[3] CSIRO Mat Sci & Engn, Clayton, Vic 3168, Australia

来源：

MACROMOLECULAR BIOSCIENCE | 2015年 / 15卷 / 01期

关键词：

antiviral; HIV polymer therapeutics; inhibitor; microbicide; polyvalency; HUMAN-IMMUNODEFICIENCY-VIRUS; DEXTRAN SULFATE; DC-SIGN; ANTIRETROVIRAL THERAPY; RADICAL POLYMERIZATION; ENVELOPE GLYCOPROTEIN; IN-VITRO; SYNTHETIC PEPTIDE; CRYSTAL-STRUCTURE; DENDRITIC CELLS;

D O I：

10.1002/mabi.201400298

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The scope of this review is to highlight the application of polymer therapeutics in an effort to curb the transmission and infection of the human immunodeficiency virus (HIV). Following a description of the HIV life cycle, the use of approved antiretroviral drugs that inhibit critical steps in the HIV infection process is highlighted. After that, a comprehensive overview of the structure and inhibitory properties of polymeric anti-HIV therapeutic agents is presented. This overview will include inhibitors based on polysaccharides, synthetic polymers, dendritic polymers, polymer conjugates as well as polymeric DC-SIGN antagonists. The review will conclude with a section that discusses the applications of polymers and polymer conjugates as systemic and topical anti-HIV therapeutics.

引用

页码：9 / 35

页数：27

共 50 条

[21] Liposomes as nanocarriers for anti-HIV therapy
Chopra, Shruti
Venkatesan, Natarajan
Betageri, Guru V.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2013, 3 (05) : 471 - 478
[22] Anti-HIV drug development - An overview
Pereira, CF
Paridaen, JTML
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (32) : 4005 - 4037
[23] Combination anti-HIV therapy via tandem release of prodrugs from macromolecular carriers
Danial, Maarten
Telwatte, Sushama
Tyssen, David
Cosson, Steffen
Tachedjian, Gilda
Moad, Graeme
Postma, Almar
POLYMER CHEMISTRY, 2016, 7 (48) : 7477 - 7487
[24] Nanomedicine in the development of anti-HIV microbicides
das Neves, Jose
Nunes, Rute
Rodrigues, Francisca
Sarmento, Bruno
ADVANCED DRUG DELIVERY REVIEWS, 2016, 103 : 57 - 75
[25] Anti-HIV B Cell Lines as Candidate Vaccine Biosensors
Ota, Takayuki
Doyle-Cooper, Colleen
Cooper, Anthony B.
Huber, Michael
Falkowska, Emilia
Doores, Katherine J.
Hangartner, Lars
Le, Khoa
Sok, Devin
Jardine, Joseph
Lifson, Jeffrey
Wu, Xueling
Mascola, John R.
Poignard, Pascal
Binley, James M.
Chakrabarti, Bimal K.
Schief, William R.
Wyatt, Richard T.
Burton, Dennis R.
Nemazee, David
JOURNAL OF IMMUNOLOGY, 2012, 189 (10) : 4816 - 4824
[26] Potent anti-HIV activity of scytovirin domain 1 peptide
Xiong, Changyun
O'Keefe, Barry R.
Byrd, R. Andrew
McMahon, James B.
PEPTIDES, 2006, 27 (07) : 1668 - 1675
[27] Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Ahmed, Yousuf
Tian, Meijuan
Gao, Yong
AIDS RESEARCH AND THERAPY, 2017, 14
[28] Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Mouquet, Hugo
Scheid, Johannes F.
Zoller, Markus J.
Krogsgaard, Michelle
Ott, Rene G.
Shukair, Shetha
Artyomov, Maxim N.
Pietzsch, John
Connors, Mark
Pereyra, Florencia
Walker, Bruce D.
Ho, David D.
Wilson, Patrick C.
Seaman, Michael S.
Eisen, Herman N.
Chakraborty, Arup K.
Hope, Thomas J.
Ravetch, Jeffrey V.
Wardemann, Hedda
Nussenzweig, Michel C.
NATURE, 2010, 467 (7315) : 591 - U117
[29] Formulation and delivery of anti-HIV rectal microbicides: Advances and challenges
Nunes, Rute
Sarmento, Bruno
das Neves, Jose
JOURNAL OF CONTROLLED RELEASE, 2014, 194 : 278 - 294
[30] Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides
Cole, AM
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (03) : 329 - 341

← 1 2 3 4 5 →